155 related articles for article (PubMed ID: 361340)
61. Parathyroidectomy in the treatment of renal osteodystrophy. Calcium dynamic studies.
Hubay CA; Gonzalez-Barcena D; Klein L; Frankel V; Eckel RE; Pearson OH
Arch Surg; 1970 Aug; 101(2):181-92. PubMed ID: 5451199
[No Abstract] [Full Text] [Related]
62. Vitamin D metabolites and their relationship to azotaemic osteodystrophy.
Mason RS; Lissner D; Wilkinson M; Posen S
Clin Endocrinol (Oxf); 1980 Oct; 13(4):375-85. PubMed ID: 7438480
[TBL] [Abstract][Full Text] [Related]
63. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
von Herrath D; Kraft D; Schaefer K; Krempien B
MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
[No Abstract] [Full Text] [Related]
64. The nature of vitamin D resistance in experimental uremia.
Kimberg DV; Baerg RD; Gershon E
Arch Intern Med; 1970 Nov; 126(5):891-5. PubMed ID: 4319936
[No Abstract] [Full Text] [Related]
65. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.
Locatelli F; Cannata-Andía JB; Drüeke TB; Hörl WH; Fouque D; Heimburger O; Ritz E
Nephrol Dial Transplant; 2002 May; 17(5):723-31. PubMed ID: 11981055
[TBL] [Abstract][Full Text] [Related]
66. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
[TBL] [Abstract][Full Text] [Related]
67. Vitamin D: the discovery of its metabolites and their therapeutic applications.
Beale MG; Chan JC; Oldham SB; Deluca HF
Pediatrics; 1976 May; 57(5):729-41. PubMed ID: 181725
[TBL] [Abstract][Full Text] [Related]
68. How important is phosphate in the pathogenesis of renal osteodystrophy?
Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
[No Abstract] [Full Text] [Related]
69. Lack of response of 1,25-dihydroxycholecalciferol to exogenous parathyroid hormone in a patient with treated pseudohypoparathyroidism.
Braun JJ; Birkenhäger JC; Visser TJ; Juttmann JR
Clin Endocrinol (Oxf); 1981 Apr; 14(4):403-7. PubMed ID: 6266703
[TBL] [Abstract][Full Text] [Related]
70. [Vitamin D metabolism and chronic kidney insufficiency].
Schaefer K; von Herrath D; Kraft D
Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
[No Abstract] [Full Text] [Related]
71. [Clinical importance of disorders of vitamin D metabolism].
Flury W
Schweiz Med Wochenschr; 1978 Jan; 108(4):129-33. PubMed ID: 341302
[TBL] [Abstract][Full Text] [Related]
72. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
[No Abstract] [Full Text] [Related]
73. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol.
Hernandez JD; Wesseling K; Boechat MI; Gales B; Salusky IB
Nat Clin Pract Nephrol; 2007 Apr; 3(4):227-32. PubMed ID: 17389892
[TBL] [Abstract][Full Text] [Related]
74. [Collagen metabolism and mineralization of uremic bone--aspects of the molecular pathology of renal osteodystrophy].
Heidbreder E; Lüke F; Heidland A
Klin Wochenschr; 1976 Apr; 54(8):341-8. PubMed ID: 178947
[TBL] [Abstract][Full Text] [Related]
75. Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide.
Verberckmoes R; Bouillon R; Krempien B
Ann Intern Med; 1975 Apr; 82(4):529-33. PubMed ID: 1119767
[TBL] [Abstract][Full Text] [Related]
76. The role of the kidney and vitamin D metabolism in health and disease.
Norman AW; Henry H
Clin Orthop Relat Res; 1974; (98):258-87. PubMed ID: 4361481
[No Abstract] [Full Text] [Related]
77. The kidney as an endocrine organ for the production of 1,25-dihydroxyvitamin D 3 , a calcium-mobilizing hormone.
DeLuca HF
N Engl J Med; 1973 Aug; 289(7):359-65. PubMed ID: 4578017
[No Abstract] [Full Text] [Related]
78. Medical treatment in primary and secondary hyperparathyroidism.
Coburn JW; Brickman AS; Massry SG
Semin Drug Treat; 1972; 2(1):117-35. PubMed ID: 4261783
[No Abstract] [Full Text] [Related]
79. Renal osteodystrophy.
Parfitt AM
Orthop Clin North Am; 1972 Nov; 3(3):681-98. PubMed ID: 4565585
[No Abstract] [Full Text] [Related]
80. Vitamin A and hyperparathyroid bone disease in uremia.
Cundy T; Earnshaw M; Heynen G; Kanis JA
Am J Clin Nutr; 1983 Dec; 38(6):914-20. PubMed ID: 6685972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
